The incidence of lymphogranuloma venereum (LGV) is low in the western world. Early LGV is characterised by bubonic disease following a painless papule or small ulcer. We report a white bisexual male who presented with a painful perianal ulcer, inguinal lymphadenitis, and concomitant infection with human immunodeficiency virus 1 (HIV-1). Chlamydia trachomatis serovar L2 was identified as the cause after polymerase chain reaction and genotyping the major outer membrane protein by restricted fragment length polymorphism. Treatment with a single dose of 1 g azithromycin was effective. This case illustrates that early LGV may mimic other genital ulcer diseases, such as genital herpes or chancroid, especially in HIV infected patients. In the western world, LGV must still be included in the differential diagnosis of bubonic disease with or without sexually acquired ulcers.
- lymphogranuloma venereum
Statistics from Altmetric.com
Lymphogranuloma venereum (LGV) is a sexually transmitted disease (STD) endemic to parts of Africa, South East Asia, South America, and some Caribbean islands. In the western world, the incidence is low and most cases are considered to be imports.1 Early stages of LGV are characterised by a marked bubonic disease in the groin after a painless papule or a shallow ulcer. Late manifestations include strictures and fistulas when the rectum is involved, and disfiguring conditions of the external genitalia, such as elephantiasis and esthiomene.2 We report a patient with a painful perianal ulcer, inguinal lymphadenitis, and a concomitant infection with human immunodeficiency virus 1 (HIV-1).
A 39 year old, bisexual white man initially presented at our STD clinic with a painful perianal ulcer, bilateral swollen lymph nodes in the groin, and general malaise. Three weeks before the onset of the symptoms he had had unprotected, receptive anal intercourse with a white man in Amsterdam. Unfortunately, partner notification was not possible because of the anonymous nature of the sexual contact in a “gay” sauna. The public health department in Amsterdam was notified about our patient, but no cases of LGV had been reported in Amsterdam in the previous 6 months. Our patient denied any overseas travel, and this sexual contact was the only sexual encounter in the previous 6 months. The patient had a history of recurrent herpes labialis and an appendectomy, but no known history of STDs. He was not taking systemic medication and denied injecting drug use. Direct diagnostic tests (dark field microscopy, Tzanck smear, and rapid plasma reagin) revealed no abnormalities. Clinical suspicion of primary genital herpes prompted us to treat with valaciclovir.
Two weeks later he presented with severe complaints. Physical examination showed a slightly febrile man with a marked swelling in the right groin. The swelling was firm, fluctuant, and slightly tender. The perianal ulcer had clearly increased in size (diameter 2.5 cm). The bottom of the fairly deep ulcer was red and showed some purulent exudate (fig 1). Remarkable features were the irregular ulcer rim and the severe pain. A clinical diagnosis of chancroid was therefore strongly suspected and he was accordingly treated with a single dose of 1 g azithromycin orally.3
Treponemal serology was positive in the TPPA and fluorescent treponemal antibody test (FTA-abs) tests, but negative in the Veneral Disease Research Laboratory (VDRL) test. Histopathological examination of an incisional biopsy from the ulcer showed a dense granulating infiltrate and atypical patterns of ulceration, but no spirochaetes were observed by immunofluorescence. No infective agents could be identified in the periodic acid-Schiff, Grocott, and Giemsa staining. A blood stained purulent aspirate was obtained from the bubo in the right groin as shown in figure 2. Haemophilus ducreyi was absent in Gram stained smears and cultures of both the aspirate and ulcer swab. H ducreyi, Treponema pallidum, and herpes simplex virus were not identified in the ulcer swab using the multiplex polymerase chain reaction (M-PCR) technique.4 However, Chlamydia trachomatis infection was demonstrated in urine and rectal specimens by PCR. C trachomatis serology showed relatively high levels of IgA and IgG antibodies (5.2 and >5.3 ratio to cut-off value, respectively; Savyon SeroCT peptide enzyme immunoassay), suggestive of invasive infection. Genotyping of the gene encoding the major outer membrane protein (MOMP) using nested PCR and restriction fragment length polymorphism (RFLP)5 identified C trachomatis serovar L2 in both the urine and rectal specimen (fig 3), confirming the diagnosis of LGV.6,7 The LGV responded well to treatment with azithromycin during the next 2 weeks.
Furthermore, the HIV serology (HIV-1) was positive with a viral load (HIV-RNA) of higher than 1.0×105 U. The CD4+ and CD8+ T lymphocyte counts were 0.27×109/l and 0.71×109/l, respectively. Chest x ray was normal and the cerebrospinal fluid showed no signs of neurosyphilis. However, on the basis of treponemal antibodies in the serum, 2 weeks after receiving the azithromycin he was additionally treated for late latent syphilis with three injections of 2.4 mU benzathine benzyl penicillin intramuscularly at weekly intervals.
Lymphogranuloma venereum is caused by C trachomatis serovars L1, L2, and L3. It causes invasive infection with preference for the regional lymph nodes. In the majority of cases, patients seek medical assistance because of buboes.1 The primary lesion, usually a small and painless papule or ulcer, may escape attention. Only 25–33% of the patients report a history of such lesions.8 Documentation on LGV and concomitant HIV infection is limited. It was suggested that HIV infection does not influence the clinical presentation of LGV.9 However, Rompalo et al10 reported that HIV infected patients (mean CD4+ count: 0.66×109/l) with genital ulcer disease (GUD) are more likely to present with deeper, larger, and multiple lesions. The patient reported here had a low CD4+ count (0.27×109/l) and presented with a large and painful perianal ulcer mimicking severe genital herpes or chancroid. The final diagnosis of LGV was based on the presence of C trachomatis serovar L2 in combination with the negative VDRL test, immunofluorescence, and Giemsa staining. Moreover, detection of H ducreyi was negative in M-PCR from the ulcer swab, and in cultures from both bubo pus and the ulcer. However, these diagnostic techniques are less than 100% sensitive.11,12
According to the current European STD guidelines, the recommended treatment of early LGV is 100 mg doxycycline twice daily for 21 days.3 Uncomplicated chlamydial infections with non-LGV strains are effectively treated with a single oral dose of 1 g azithromycin.13 Clinical evidence is lacking on its use in LGV.14 Our patient responded well to a single dose of 1 g azithromycin, demonstrating its possible effectiveness in early LGV. Treatment recommendations in HIV infected patients are the same, although it is presumed that the time to heal may be prolonged in these patients.15 Recently, Moodley et al16 reported that HIV-1 co-infection was not associated with a decreased response to treatment. The findings in our patient support their observations.
We conclude that in the western world LGV must still be included in the differential diagnosis of bubonic disease with or without sexually acquired ulcers, even when the patient denies sexual contact with partners from endemic regions. Physicians in the West must also remain vigilant for the possibility of local outbreaks of LGV as a result of ever increasing travel to and from the endemic areas.
Although very rare, this case proves that lymphogranuloma venereum (LGV) still exists in the West, and therefore western physicians must remain vigilant for local outbreaks of LGV.
In HIV infected patients, the presentation of LGV may be unusual mimicking genital ulcer diseases such as chancroid and genital herpes.
The presented case suggests that a single dose of 1 g azithromycin is possibly effective in treating early LGV.
We thank Dr B Tank, Department of Dermatology and Venereology, for correcting the English; Mr J van der Stek, Department of Dermatology and Venereology, for preparing the clinical pictures; and Mrs H F M Willemse, Department of Medical Microbiology and Infectious Diseases, is acknowledged for performing the necessary laboratory work.
CONTRIBUTORS RFN was responsible for clinically managing the patient, reviewed the literature, and wrote the manuscript; JMO was responsible for the laboratory diagnosis, advised on microbiological aspects of managing the patient, and reviewed and revised the manuscript; WIvdM supervised the management of the patient and reviewed and revised the manuscript; HAMN is Head of the Department of Dermatology and Venereology and critically commented on the manuscript.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.